Abstract~Recently we have shown that intracellular low molecular weight (LMW) iron increases during ischemia. It is hypothesized that this increase in LMW iron during ischemia underlies the reported hydrogen peroxide toxicity toward ischemic hearts. To investigate this hypothesis, rat hearts were subjected to 15 min of no-flow ischemia and reperfused with buffer saturated against 95% N2 and 5% CO2 (anoxic reperfusion) for 7 min. Hearts were then switched to buffer saturated against 95% 02 and 5% CO2 (reoxygenation) to assess functional recovery. The cardiac function recovered to 80 _ 7% of the preischemic value. When the anoxic reperfusion was applied in the presence of 10 #M hydrogen peroxide, functional recovery after reoxygenation was 47 _+ 7%. Hearts that were peffused with deferoxamine before ischemia and then subjected to ischemia and anoxic reperfusion in the presence of 10 #M hydrogen peroxide recovered to 78 _ 8%. Immediate reoxygenation after ischemia led to only 45 _ 6% recovery of function. During ischemia, LMW iron increased from 49 _ 45 to 183 +_ 45 pmol/mg protein (p < .05) and decreased to 58 +-38 pmol/mg protein (p < .05) during the subsequent anoxic perfusion. Rat hearts preloaded with deferoxamine showed a slightly higher LMW iron content than normal (85 _ 23 and 49 _ 45 pmol/mg protein, respectively; n.s.), which showed a small, nonsignificant increase up to 136 _+ 42 pmol/mg protein after 15 min of ischemia. No significant changes were found in reduced and oxidized glutathione content and glutathione peroxidase or catalase activities under those conditions. Our results indicate that hydrogen peroxide toxicity is determined by the amount of catalytic iron in the LMW pool and not by a decrease in antioxidant defense capacity to hydrogen peroxide.
INTRODUCTION
In recent years it has been well established that reoxygenation of ischemic tissue leads to the generation of reactive oxygen species (ROS). L2 It is likely that those ROS contribute to the reperfusion syndrome by damaging proteins, causing breakage of DNA strands, and initiating lipid peroxidation. [2] [3] [4] In the presence of a catalytic transition metal such as iron, the toxicity of the ROS is tremendously increased by the conversion of hydrogen peroxide to the highly reactive hydroxyl radical. 5 Under physiological conditions, iron is stored or contained in proteins in a noncatalytic form. 6 Only a very small amount is thought to be present in a low molecular weight (LMW) pool 7'8 in a form that has been shown to catalyze hydroxyl radical formation. 9-~2 In a recent study from our laboratory, 13 it has been shown that intracellular LMW iron increases dramatically during ischemia in isolated rat hearts. In vitro, iron can be released from ferritin through a reductive mechanism, and this release is enhanced by a lower pH. 14 Therefore, it has been proposed 13 that this reallocation of iron during ischemia is caused by reducing equivalents arising during ischemia and that this is greatly enhanced by the acidification that occurs in the ischemic hearts. 15 The role of iron in postischemic free radical toxicity has been substantiated by studies in which iron chelators that inhibit in vitro lipid peroxidation attenuate reperfusion injury in a variety of experimental animal models. ~6-~9 However, this has never been studied in relation to the amount of catalytic iron in postischemic tissue. Shattock et al.20 have shown that ischemic rat hearts were much more sensitive to hydrogen peroxide than normoxic hearts. This raised the question of whether the rise in the intracellular LMW iron pool during ischemia as shown by us underlies the increased susceptibility toward hydrogen peroxide. To investigate this, we have studied hydrogen peroxide toxicity in postischemic rat hearts in relation to the LMW iron pool and the hydrogen peroxide defense system.
MATERIALS AND METHODS

Animals and perfusion protocol
Twelve-to fourteen-week-old male Wistar rats were used. After a brief anaesthesia with diethyl ether, the hearts were excised and placed in ice-cold Tyrode buffer. The hearts were cannulated through the aorta and perfused retrogradely according to Langendorff. 21 Perfusions were carried out at 37°C with Tyrode buffer containing 128 mM NaC1, 4.7 mM KC1, 1.25 mM CaC12, 20.2 mM NaHCO3, 0.4 mM NaH2PO4, 1 mM MgC12, and 11 mM glucose, pH 7.4. The buffer was saturated with 95% 02 and 5% CO2. Tyrode buffer was made anoxic by saturation with 95% N2 and 5% CO2 for at least 1 h. Perfusion pressure was held constant at 80 cm water pressure.
Experimental design
To assess hydrogen peroxide toxicity in the absence of superoxide, hearts were subjected to 15 min of warm no-flow ischemia and reperfused with anoxic buffer either with or without 10 #M hydrogen peroxide for 7 min. After this anoxic reperfusion, the hearts were perfused with oxygenated Tyrode buffer to assess functional recovery. The effect of iron chelation on this insult was investigated by preloading hearts with 50 #M deferoxamine during a 10-minute perfusion immediately before ischemia and addition of 10/~M hydrogen peroxide during the anoxic reperfusion period. During ischemia, the hearts were submerged in warm (37°C) Tyrode buffer, which was gassed with 95% N2 and 5% CO2. To assess hydrogen peroxide toxicity directly after anoxia, hearts were subjected to 15 min of anoxic perfusion, then switched to anoxic buffer containing 10 #M hydrogen peroxide for 7 min, and compared with hearts that were perfused with anoxic buffer for 22 min.
Catalase, glutathione peroxidase, reduced glutathione, total glutathione, and LMW iron were determined in separate groups of hearts subjected to the appropriate perfusion protocol.
Functional parameters
Lactate dehydrogenase (LDH) release in the coronary effluent, as a measure of tissue damage, and coronary flow were determined as described earlier, is Apex displacement was detected with a smooth muscle transducer. Contractility, as a measure of cardiac work, was calculated as the product of apex-amplitude and apexfrequency, which were recorded every 30 s. Data acquisition was started after the hearts had shown a stable contractility for 10 min. The mean value of the contractility of each heart during 10 min before ischemia was set at 100%, and subsequent performance was expressed as a percentage of preischemic contractility.
Antioxidant, antioxidant enzymes, and LMW iron determinations
After the appropriate perfusions, hearts were immediately homogenized to a 10% homogenate in 100 mM ice-cold Tris/HC1, pH 7.4. The homogenate was centrifuged at 10.000 g for 15 min.
Reduced glutathione was determined after protein precipitation by 5% trichloric acid of the resulting supernatant by reduction of 5,5-dithio-bis-2-nitrobenzoic acid (DTNB) measured as absorbance at 412 nm. Total glutathione was determined by the reduction of DTNB in the presence of reduced nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione reductase. 22 Glutathione peroxidase was determined as described elsewhere 23 and expressed as units/mg protein (1 unit = 1 #mol NADPH/min). Protein concentration of the supernatant was determined using Biuret reagents with bovine serum albumin as standard. Catalase activity was assessed as the disappearance of hydrogen peroxide as determined at 240 nm at a hydrogen peroxide concentration between 7 and 9 mM and expressed as micromoles per minute.
LMW iron was determined in the supernatant as described in detail elsewhere. ~3
Statistics
All data are presented as means ___ standard error of the mean (SEM). To evaluate differences between groups, one-way analysis of variance was performed on the data using the Stata release 2.0 (Computing Resource Centre, Los Angeles, CA).
Chemicals
Unstabilized hydrogen peroxide was obtained from Merck (Darmstadt, Germany; MOS selectipure, 12341) to avoid confounding effects of stabiliser substances. Deferoxamine Mesylate (deferoxamine) was obtained from Sigma Chemical Co. (St. Louis, MO). 
RESULTS
Functional recovery and tissue damage
To study the toxicity of hydrogen peroxide on the rat heart, the effect of this compound on cardiac function and tissue damage was established under various conditions. Rat hearts that were perfused with normoxic buffer containing 10 #M hydrogen peroxide for 30 min suffered no loss of contractility or LDH release (results not shown).
Ischemia. Immediate reoxygenation of ischemic hearts impaired cardiac function (45 _+ 6% recovery; Fig.  1A) , while a 7-min period of anoxic perfusion preceding reoxygenation led to a much better (80 ___ 7%) restoration of contractility (Fig. 1A) . However, if 10 #M hydrogen peroxide was administered during this anoxic perfusion, a recovery of only 47 _+ 6% was found (Fig. 1B) . To investigate whether this effect of hydrogen peroxide is mediated by an iron-dependent mechanism, the hearts were perfused with 50 #M deferoxamine for 10 min before ischemia. Under those conditions, the hydrogen peroxide included in the anoxic buffer did not significantly decrease the recovery of the contractility (78 ___ 9%, Fig. 1B) .
The susceptibility of the Langendorff rat heart to hydrogen peroxide was also studied by the release of LDH in the coronary effluent as a parameter of tissue damage. Analysis of variance showed that hearts, reoxygenated immediately after 15 min of ischemia, released more LDH than hearts that were reperfused for the first 7 min after ischemia with anoxic buffer and then reoxygenated ( Fig. 2A; anoxic buffer contained 10 #M hydrogen peroxide, the LDH in the coronary effluent increased significantly ( Fig. 2B ; p < .01 compared to anoxia without hydrogen peroxide, Fig. 2A ). The increased release of LDH was prevented by preloading of the hearts with deferoxamine ( Fig. 2B ; p < .01, for the difference in the absence of deferoxamine).
Anoxia. To investigate whether the toxicity depends on a preceding period of ischemia, hydrogen peroxide toxicity was assessed after 15 min of anoxic perfusion. The results showed that hydrogen peroxide present during the last 7 min of a period of 22 min of anoxia did not impair the contractility of the reoxygenated hearts compared to the hearts subjected to anoxic perfusion without hydrogen peroxide (94 _+ 5 and 96 _+ 4%, respectively, Fig. 3 ). In the coronary effluent from these hearts, very little LDH was detectable (<0.05 mU/g wet weight/min). Furthermore, we have shown earlier that reoxygenation after anoxic perfusion did not lead to any loss of contractility and that LMW iron does not increase under those conditions) 3
Low molecular weight iron
Because deferoxamine pretreatment abolished hydrogen peroxide toxicity after ischemia, the amount of iron in the LMW pool was determined under the various conditions (Fig. 4) . During ischemia the amount of iron in the LMW pool increased from 49 _+ 16 to 183 _+ 45 pmol/mg protein (p < .05), confirming our earlier findings. ~3 Upon reperfusion with anoxic buffer in the presence or absence of hydrogen peroxide, the LMW iron pool returned to about normal values over the next 7 min (22 _+ 18 and 59 +_ 29 pmol/mg protein, respectively; p < .05) and remained fairly constant after reoxygenation. Hearts preloaded with deferoxamine showed a slightly higher LMW iron content than normal (85 _+ 23 and 49 _+ 45 pmol/mg protein, respectively; n.s.), but ischemia did not lead to a significant increase of LMW iron in those hearts (136 _+ 42 pmol/ mg protein after 15 rain; n.s.). Anoxic perfusion for 15 min did not cause a significant change in LMW iron, and neither did the additional 7 rain of anoxic reperfusion in the presence of hydrogen peroxide. (61 _+ 29, 55 _+ 32, and 42 +_ 25 pmol/mg protein respectively, n.s.).
Antioxidant defense system
Besides a role of LMW iron, it is possible that the increased susceptibility of the (post-)ischemic heart to hydrogen peroxide is caused by a decrease in the hydrogen peroxide metabolizing enzymes (i.e., catalase and glutathione peroxidase). A decrease of reduced glutathione, the substrate of the latter antioxidant enzyme, will also lead to impaired detoxification of hydrogen peroxide. Therefore, the activities of catalase and glutathione peroxidase, and the total glutathione and reduced glutathione content, were determined under the various conditions. Because hydrogen peroxide had no effect after a period of anoxia, these parameters were not determined in these hearts. Table 1 shows that the antioxidant defense system did not vary significantly between all groups (one-way analysis of variance, using the Bonferonni correction for multiple comparisons). DISCUSSION The main conclusion to be drawn from the present study is that the increased susceptibility to hydrogen peroxide of the postischemic heart is related to the amount of catalytic LMW iron and not due to a decrease in hydrogen peroxide metabolizing capacity.
Our data showed that a short period of anoxic reperfusion after ischemia causes a much better recovery of the contractility compared to immediate reoxygenation. Previously, the beneficial effect of hypoxic reperfusion was attributed to a decrease in the production of ROS during reoxygenation. 24 However, others have shown that after a short period of anoxic reperfusion, a burst of free radicals occurs during reoxygenation, which is of similar magnitude to the burst that occurs during immediate reoxygenation. In that study, no radicals were observed during the anoxic reperfusion period. 25 In the present study, we have shown that during the anoxic reperfusion period the LMW iron pool, which was increased during ischemia, returned to values that did not differ from normoxic hearts. Apparently, under those conditions the amount of free iron became too low to catalyze the formation of hydroxyl radicals in sufficient amounts to cause tissue damage upon reoxygenation. This hypothesis is substantiated by our finding that hydrogen peroxide was only toxic when the LMW pool was increased. The presence of deferoxamine did not affect the magnitude of the LMW iron pool at the end of ischemia (183 ___ 45 versus 136 ___ 42 pmol/mg protein, p = n.s.). During ischemia in the absence of deferoxamine, the released iron will be chelated to the natural chelators of the LMW pool, in which form it is available to catalyse the Haber-Weiss reactions. However, in the presence of deferoxamine the released iron will be chelated as ferrioxamine, which does not catalyse these reactions. Smith et al. have shown that the protective effect of deferoxamine indeed depends on iron chelation, since the protection is lost when an equimolar amount of ferrioxamine is used. 16 In the present study, hearts could cope with hydrogen peroxide immediately after ischemia only if the released iron had been rendered noncatalytic by the iron chelator deferoxamine. Therefore, we conclude that hydrogen peroxide is toxic after ischemia due to an iron-dependent mechanism.
How the drop in the LMW iron pool during anoxic reperfusion occurred is not known, but it is conceivable that the free iron was washed out. Calculation showed that approximately 10 nmol of iron were lost. This is so little that it cannot be determined if diluted in the coronary effluent. Reuptake of iron by ferritin is not very likely because this process is oxygen dependent. 26 Normally, hydrogen peroxide is detoxified effectively by the antioxidant enzymes catalase and glutathione peroxidase, but if the oxygen supply is suddenly increased after an ischemic period the formation of ROS may overwhelm the antioxidant enzyme system. Under such a condition and if accompanied by an increased amount of ferrous iron in the LMW iron pool, hydrogen peroxide is immediately converted to the highly reactive hydroxyl radical, leading to loss of cardiac function and tissue damage.
From a clinical point of view, our results indicate that it may be beneficial to flush an ischemic organ with anoxic buffer or venous blood before reoxygenation, because this could lead to normalized levels of LMW iron and attenuation of reperfusion injury without the need for pharmacological interventions.
